CD-008-0045

· ChemRar Research and Development Institute, LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CD-008-0045, covering 2020-08-24 to 2020-10-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Efficacy and Safety of CD-008-0045 in Patients With Generalized Anxiety Disorder [Phase 3]